Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 18, 2008 - Issue 9
Submit an article Journal homepage
82
Views
7
CrossRef citations to date
0
Altmetric
Patent Evaluation

Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists

Pfi zer: WO2008041095

Peter Norman Norman Consulting, 18 Pink Lane, Burnham, Buckinghamshire, SL1 8JW, UK [email protected]
, MBA PhD
Pages 1091-1096 | Published online: 21 Aug 2008

Bibliography

  • Kaik G. Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease. Wien Klin Wochenschr 1975;87:653-6
  • Chrischilles E, Gilden D, Kubisiak J, et al. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am J Manag Care 2002;8:902-11
  • Friedman M, Serby CW, Menjoge SS, et al. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest 1999;115(3):635-41
  • Fitzgerald MF, Fox JC. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Drug Discov Today 2007;12:479-86
  • Norman P. Dual-acting β2 agonists/muscarinic antagonists. Expert Opin Ther Patents 2006;16:1327-31
  • Theravance, Inc. Crystalline form of a biphenyl compound. WO2006023454; 2006
  • Glaxo Group Ltd. Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2- (2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl) ethylaminoimethyl]}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders. WO2007090859; 2007
  • Theravance, Inc. Crystalline forms of a dimethylphenyl compound. WO2007127297; 2007
  • Argenta Discovery Press Release 31 January 2007. Available from: http://www.forbion.com/downloads/AstraZeneca_sign_COPD_31_01_2007.pdf
  • Argenta Discovery Ltd. Azole and thiazole derivatives and their use. WO2007017669; 2007
  • Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses. WO2007017670; 2007
  • Argenta Discovery Ltd. Nitrogen containing heterocyclic compounds useful as M3-receptor modulators. WO2008023157; 2008
  • Pfizer Ltd. Amine derivatives. WO2007107828; 2007
  • Pfizer, Inc. Pfizer Pipeline 28 February 2008. Available from: http://media.pfizer.com/files/research/pipeline/2008_0228/pipeline_2008_0228.pdf
  • Pfizer Ltd. Compounds having beta-agonist activity. WO2005092841; 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.